Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grupo Azevedos is a prominent Portuguese pharmaceutical group with a heritage dating back to 1772, specializing in the development, manufacturing, and commercialization of medicines. The company operates across the entire pharmaceutical value chain, including R&D, large-scale production through its specialized subsidiaries Sofarimex and Farmalabor, and integrated logistics via Logifarma. Its product portfolio is primarily focused on therapeutic areas such as pain management, respiratory health, anti-infectives, and the central nervous system. As a significant player in the CDMO sector, Grupo Azevedos provides high-quality manufacturing services for global pharmaceutical companies, exporting to more than 90 countries. The group maintains a dominant position in the Portuguese market and a strong international presence, particularly in Portuguese-speaking African countries and the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo Azevedos.